EDROMEK Trademark

Trademark Overview

On Thursday, April 21, 2011, a trademark application was filed for EDROMEK with the United States Patent and Trademark Office. The USPTO has given the EDROMEK trademark a serial number of 85301357. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 1, 2014. This trademark is owned by Glaxo Group Limited. The EDROMEK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
edromek

General Information

Serial Number85301357
Word MarkEDROMEK
Filing DateThursday, April 21, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 1, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "EDROMEK" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 25, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiddlesex UB060NN

Trademark Events

Event DateEvent Description
Monday, December 1, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 1, 2014ABANDONMENT - NO USE STATEMENT FILED
Friday, April 18, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 17, 2014EXTENSION 5 GRANTED
Monday, April 14, 2014EXTENSION 5 FILED
Monday, April 14, 2014TEAS EXTENSION RECEIVED
Saturday, November 2, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 1, 2013EXTENSION 4 GRANTED
Monday, October 21, 2013EXTENSION 4 FILED
Monday, October 21, 2013TEAS EXTENSION RECEIVED
Saturday, May 11, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 10, 2013EXTENSION 3 GRANTED
Tuesday, April 9, 2013EXTENSION 3 FILED
Friday, May 3, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 9, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 12, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 11, 2012EXTENSION 2 GRANTED
Tuesday, October 9, 2012EXTENSION 2 FILED
Wednesday, October 10, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 9, 2012TEAS EXTENSION RECEIVED
Saturday, February 4, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 2, 2012EXTENSION 1 GRANTED
Thursday, February 2, 2012EXTENSION 1 FILED
Thursday, February 2, 2012TEAS EXTENSION RECEIVED
Tuesday, October 25, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 30, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2011PUBLISHED FOR OPPOSITION
Wednesday, July 27, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 27, 2011ASSIGNED TO LIE
Wednesday, July 6, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 6, 2011EXAMINER'S AMENDMENT ENTERED
Wednesday, July 6, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 6, 2011EXAMINERS AMENDMENT E-MAILED
Wednesday, July 6, 2011EXAMINERS AMENDMENT -WRITTEN
Thursday, June 30, 2011ASSIGNED TO EXAMINER
Monday, April 25, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 25, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

edromek pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological